These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26458226)

  • 1. Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.
    Thaden JT; Fowler VG; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):49-54. PubMed ID: 26458226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review.
    McDanel J; Schweizer M; Crabb V; Nelson R; Samore M; Khader K; Blevins AE; Diekema D; Chiang HY; Nair R; Perencevich E
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1209-1215. PubMed ID: 28758612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
    Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae.
    Denkel LA; Maechler F; Schwab F; Kola A; Weber A; Gastmeier P; Pfäfflin F; Weber S; Werner G; Pfeifer Y; Pietsch M; Leistner R
    Clin Microbiol Infect; 2020 Aug; 26(8):1046-1051. PubMed ID: 31809805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in acute care and rehabilitation hospitals.
    Kohlenberg A; Schwab F; Rüden H
    Epidemiol Infect; 2012 Mar; 140(3):528-34. PubMed ID: 21676355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
    Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
    Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
    Wollheim C; Guerra IM; Conte VD; Hoffman SP; Schreiner FJ; Delamare AP; Barth AL; Echeverrigaray S; Costa SO
    Braz J Infect Dis; 2011; 15(2):138-43. PubMed ID: 21503400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China.
    Quan J; Zhao D; Liu L; Chen Y; Zhou J; Jiang Y; Du X; Zhou Z; Akova M; Yu Y
    J Antimicrob Chemother; 2017 Jan; 72(1):273-280. PubMed ID: 27624571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
    Khanfar HS; Bindayna KM; Senok AC; Botta GA
    J Infect Dev Ctries; 2009 May; 3(4):295-9. PubMed ID: 19759493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.
    Lee SY; Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1226-32. PubMed ID: 17080381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
    Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D
    Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of community-onset extended-spectrum β-lactamase-producing
    Richelsen R; Smit J; Anru PL; Schønheyder HC; Nielsen H
    Infect Dis (Lond); 2020 Aug; 52(8):547-556. PubMed ID: 32401562
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
    Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.